The Talk
That Changes
the Room
investment case
for women's health.
Delivered live.
The Growth Strategy Hiding in Plain Sight
Productivity stagnation, demographic decline, and healthcare costs that won't stop compounding aren't separate crises. They're symptoms of the same structural underinvestment, and women's health is at the center of all of them. In this keynote, Marissa presents the economic argument she's spent 25 years building: women's health isn't a cause dressed up as a business case. It's the business case. She draws from her experience as a four-time CEO, global nonprofit founder, and investor to show audiences what the data actually says, which organizations are already acting on it, and exactly what it costs to keep treating women's health as optional.
Your audience walks away with:
Best for: Corporate leadership summits, investor conferences, health system board retreats, industry conferences.
Innovation Doesn't Start Where You Think It Does
The most creative solutions in women's health aren't coming from Boston or Basel. They're coming from Nairobi, São Paulo, and Mumbai, built by people who can't afford to over-engineer. Marissa draws on her experience running HERhealthEQ across nine countries and investing in global medtech ventures to show why the next wave of women's health infrastructure will be built outside the traditional centers of power. She makes the case that organizations still operating with a US-and-Europe-only lens are missing what might be the largest addressable market opportunity in global healthcare.
Your audience walks away with:
Best for: Global health forums, development finance convenings, corporate audiences with international footprints, ESG and impact investor events.
What It Takes to Build in a Market the World Keeps Undervaluing
Most people who talk about women's health are commentators. Marissa is someone who has raised capital in rooms where she was told the market was too small, navigated FDA approvals for technology that didn't have a category, and bootstrapped a nonprofit like a startup because that's the only way it was going to survive. In this keynote, she tells the real stories from 25 years of operating at the intersection of technology, capital, and women's health, including the funding bias she's experienced firsthand, the structural advantages that make this market so compelling, and what it looks like when an engineer decides to stop waiting for someone else to fix the problem.
Your audience walks away with:
Best for: Entrepreneurship and innovation events, women's leadership summits, medtech industry conferences, university and executive education programs.
